While other major pharmaceutical companies are scrambling for a spot in Kendall Square's hotbed of biotechnology, GlaxoSmithKline is closing the Cambridge headquarters of its Sirtris Pharmaceuticals Inc. subsidiary. Glaxo bought Sirtris for $720 ...
See all stories on this topic »
↧
GlaxoSmithKline to close Sirtris unit in Cambridge Alerts - "GlaxoSmithKline"
↧